Boston Private Bank & Trust’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Boston Private Bank & Trust’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$1K	Hold	763	–	–	﹤0.01%	1060
2014 Q4	$1K	Sell	763 -2,500	-77%	-$1.71K	﹤0.01%	1144
2014 Q3	$2K	Hold	3,263	–	–	﹤0.01%	1013
2014 Q2	$2K	Sell	3,263 -600	-16%	-$290	﹤0.01%	959
2014 Q1	$1K	Sell	3,863 -300	-7%	-$112	﹤0.01%	1009
2013 Q4	$1K	Sell	4,163 -300	-7%	-$363	﹤0.01%	1041
2013 Q3	$9K	Hold	4,463	–	–	﹤0.01%	824
2013 Q2	$8K	Buy	+4,463	New	+$7.84K	﹤0.01%	814

Other funds holding GCVRZ

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

MCM

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

CPM

Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Boston Private Bank & Trust's GCVRZ Position: Q1 2015 in Review

Boston Private Bank & Trust held its Sanofi Contingent Value Rights (GCVRZ) position steady in Q1 2015 at 763 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1060.

Boston Private Bank & Trust first reported a position in GCVRZ in Q2 2013 and has held it in 8 quarters since. The position peaked at $9K in Q3 2013. 115 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2015.

Boston Private Bank & Trust held 763 shares of Sanofi Contingent Value Rights worth $1K as of Q1 2015.
Boston Private Bank & Trust left its Sanofi Contingent Value Rights share count unchanged in Q1 2015.
Sanofi Contingent Value Rights made up ﹤0.01% of Boston Private Bank & Trust's portfolio in Q1 2015, its #1060 holding.
Boston Private Bank & Trust first reported a position in Sanofi Contingent Value Rights in Q2 2013 and has held it in 8 quarters since.
Boston Private Bank & Trust's Sanofi Contingent Value Rights position peaked at $9K in Q3 2013.
115 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.